anti synapsin Search Results


93
Alomone Labs synapsin ii
A. Immunofluorescence images from naïve or 5HT6-GGECO1-expressing cultured mouse neurons (from cortex and CA1) showing the distribution of GABA-B1 receptors (magenta) in primary cilia positive for <t>AC3</t> (green). Intensity profiles from lines drawn along the cilia are shown to the right and further show the confinement of GABA-B1 receptors to the cilia base of cultured neurons. B. Quantification of GABA-B1 receptor enrichment at the cilia base in naïve cultured neurons or cultured cortical and hippocampal neurons expressing 5HT6-GGECO1 (naïve 2,76±0,37; Cx 8,18±0,91; Hipp 4,94±0,44 arbitrary units). GABA-B1 positive segment length was measured for each group and found significantly different (naïve, Cx and Hipp, in µm: 2,78±0,37; 8,18±0,91; 5,03±0,39; mean±SEM; Kruskal-Wallis ANOVA followed by multiple comparisons, naïve n=12, Cx n=22, Hipp n=38, for A & B). C. Simultaneous recording of cytoplasmic (grey) and ciliary (pink) calcium activities from a neuron before and after stimulation with 100nM baclofen. Activation of metabotropic GABA receptors was without effect on the frequency of somatic events while ciliary signaling was increased by the agonist. Positive deviations from baseline were computed over time to produce ciliary activity count traces (black, lower panel). D. Averaged activity counts corresponding to neurons in control (blue) baclofen (100nM, black) and TTX (1 µM) + baclofen (100nM, grey) showing an increase of activity after stimulation with baclofen. E. Quantification of activity changes was performed in a pair wise fashion, comparing the averaged activity during initial vs final period (control) and baseline vs baclofen (either in the absence of presence of TTX). Time lacked an effect on activity (control P=0,4332) while baclofen stimulation led to a significant increase in both - /+ TTX conditions (respectively P=0,0002 and P=0,0039; two tailed Wilcoxon matched-pairs signed rank test) F. To test whether abolition of action potentials had an impact on spontaneous ciliary activity, recordings in control and TTX (initial 20 minutes both groups) were compared. Statistical analysis showed no difference (P=0,1468 Mann-Whitney two tailed t-test). G. Immunofluorescence images showing the distribution of primary cilia (AC3; green) and synapses <t>(Synapsin</t> II; magenta) in cultured cortical neurons. Boxed areas are magnified to the right. Scatter plot to the left shows Synapsin II fluorescence intensity at primary cilia and random locations within the same sample (P=0,3696 Wilcoxon matched pairs signed rank test).
Synapsin Ii, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Anti-Synapsin+II+(SYN2)+Antibody/bio_rxiv__2025__05__26__656109-33-24-26
Average 93 stars, based on 1 article reviews
synapsin ii - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
PhosphoSolutions synapsin
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Synapsin, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Anti-Synapsin+I+Antibody/pmc02586268-96-31-35
Average 96 stars, based on 1 article reviews
synapsin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc synapsin 1 antibody
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Synapsin 1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+Antibody/pm28729214-101-35-38
Average 96 stars, based on 1 article reviews
synapsin 1 antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti phospho synapsin 1 ser9
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Anti Phospho Synapsin 1 Ser9, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Phospho-Synapsin+(Ser9)+Antibody/ppr0582158-50-42-56
Average 94 stars, based on 1 article reviews
anti phospho synapsin 1 ser9 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Proteintech syn1
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Syn1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/SYN1-Specific+Antibody/pm41616945-105-54-56
Average 95 stars, based on 1 article reviews
syn1 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse anti synapsin ia b
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Mouse Anti Synapsin Ia B, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+Ia%2Fb+Antibody/pmc09587155-73-41-45
Average 93 stars, based on 1 article reviews
mouse anti synapsin ia b - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio anti syn1
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Anti Syn1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Anti-Synapsin+I%2FSYN1+Antibody+Picoband/pm41566018-150-48-50
Average 90 stars, based on 1 article reviews
anti syn1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Novus Biologicals synapsin 1
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Synapsin 1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+I+%5Bp+Ser9%5D+Antibody+(SR2212)/pmc01973147-250-27-28
Average 90 stars, based on 1 article reviews
synapsin 1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Novus Biologicals anti synapsin
Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific <t>for</t> <t>PP2Aα</t> (top bands) and <t>synapsin</t> (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.
Anti Synapsin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+I+Antibody/pmc03972420-114-28-31
Average 93 stars, based on 1 article reviews
anti synapsin - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Novus Biologicals synapsin
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Synapsin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+I+Antibody/pm37175535-395-18-21
Average 93 stars, based on 1 article reviews
synapsin - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology mouse monoclonal anti synapsin iia antibody
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Mouse Monoclonal Anti Synapsin Iia Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+IIa+Antibody/pmc03459819-61-6-16
Average 92 stars, based on 1 article reviews
mouse monoclonal anti synapsin iia antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Biorbyt anti αsma
Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels <t>of</t> <t>PSD95,</t> <t>synapsin,</t> synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.
Anti αsma, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+synapsin/Synapsin+II+antibody/pmc11940605-103-51-54
Average 93 stars, based on 1 article reviews
anti αsma - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


A. Immunofluorescence images from naïve or 5HT6-GGECO1-expressing cultured mouse neurons (from cortex and CA1) showing the distribution of GABA-B1 receptors (magenta) in primary cilia positive for AC3 (green). Intensity profiles from lines drawn along the cilia are shown to the right and further show the confinement of GABA-B1 receptors to the cilia base of cultured neurons. B. Quantification of GABA-B1 receptor enrichment at the cilia base in naïve cultured neurons or cultured cortical and hippocampal neurons expressing 5HT6-GGECO1 (naïve 2,76±0,37; Cx 8,18±0,91; Hipp 4,94±0,44 arbitrary units). GABA-B1 positive segment length was measured for each group and found significantly different (naïve, Cx and Hipp, in µm: 2,78±0,37; 8,18±0,91; 5,03±0,39; mean±SEM; Kruskal-Wallis ANOVA followed by multiple comparisons, naïve n=12, Cx n=22, Hipp n=38, for A & B). C. Simultaneous recording of cytoplasmic (grey) and ciliary (pink) calcium activities from a neuron before and after stimulation with 100nM baclofen. Activation of metabotropic GABA receptors was without effect on the frequency of somatic events while ciliary signaling was increased by the agonist. Positive deviations from baseline were computed over time to produce ciliary activity count traces (black, lower panel). D. Averaged activity counts corresponding to neurons in control (blue) baclofen (100nM, black) and TTX (1 µM) + baclofen (100nM, grey) showing an increase of activity after stimulation with baclofen. E. Quantification of activity changes was performed in a pair wise fashion, comparing the averaged activity during initial vs final period (control) and baseline vs baclofen (either in the absence of presence of TTX). Time lacked an effect on activity (control P=0,4332) while baclofen stimulation led to a significant increase in both - /+ TTX conditions (respectively P=0,0002 and P=0,0039; two tailed Wilcoxon matched-pairs signed rank test) F. To test whether abolition of action potentials had an impact on spontaneous ciliary activity, recordings in control and TTX (initial 20 minutes both groups) were compared. Statistical analysis showed no difference (P=0,1468 Mann-Whitney two tailed t-test). G. Immunofluorescence images showing the distribution of primary cilia (AC3; green) and synapses (Synapsin II; magenta) in cultured cortical neurons. Boxed areas are magnified to the right. Scatter plot to the left shows Synapsin II fluorescence intensity at primary cilia and random locations within the same sample (P=0,3696 Wilcoxon matched pairs signed rank test).

Journal: bioRxiv

Article Title: GABA-induced Ca 2+ signaling in the primary cilium of neurons

doi: 10.1101/2025.05.26.656109

Figure Lengend Snippet: A. Immunofluorescence images from naïve or 5HT6-GGECO1-expressing cultured mouse neurons (from cortex and CA1) showing the distribution of GABA-B1 receptors (magenta) in primary cilia positive for AC3 (green). Intensity profiles from lines drawn along the cilia are shown to the right and further show the confinement of GABA-B1 receptors to the cilia base of cultured neurons. B. Quantification of GABA-B1 receptor enrichment at the cilia base in naïve cultured neurons or cultured cortical and hippocampal neurons expressing 5HT6-GGECO1 (naïve 2,76±0,37; Cx 8,18±0,91; Hipp 4,94±0,44 arbitrary units). GABA-B1 positive segment length was measured for each group and found significantly different (naïve, Cx and Hipp, in µm: 2,78±0,37; 8,18±0,91; 5,03±0,39; mean±SEM; Kruskal-Wallis ANOVA followed by multiple comparisons, naïve n=12, Cx n=22, Hipp n=38, for A & B). C. Simultaneous recording of cytoplasmic (grey) and ciliary (pink) calcium activities from a neuron before and after stimulation with 100nM baclofen. Activation of metabotropic GABA receptors was without effect on the frequency of somatic events while ciliary signaling was increased by the agonist. Positive deviations from baseline were computed over time to produce ciliary activity count traces (black, lower panel). D. Averaged activity counts corresponding to neurons in control (blue) baclofen (100nM, black) and TTX (1 µM) + baclofen (100nM, grey) showing an increase of activity after stimulation with baclofen. E. Quantification of activity changes was performed in a pair wise fashion, comparing the averaged activity during initial vs final period (control) and baseline vs baclofen (either in the absence of presence of TTX). Time lacked an effect on activity (control P=0,4332) while baclofen stimulation led to a significant increase in both - /+ TTX conditions (respectively P=0,0002 and P=0,0039; two tailed Wilcoxon matched-pairs signed rank test) F. To test whether abolition of action potentials had an impact on spontaneous ciliary activity, recordings in control and TTX (initial 20 minutes both groups) were compared. Statistical analysis showed no difference (P=0,1468 Mann-Whitney two tailed t-test). G. Immunofluorescence images showing the distribution of primary cilia (AC3; green) and synapses (Synapsin II; magenta) in cultured cortical neurons. Boxed areas are magnified to the right. Scatter plot to the left shows Synapsin II fluorescence intensity at primary cilia and random locations within the same sample (P=0,3696 Wilcoxon matched pairs signed rank test).

Article Snippet: The following primary antibodies (1/300 dilutions) were used: ARL13b (Abcam ab136648), AC3 (Abcam ab277619), AC3 (Alomone AAR-043), NeuN (Sigma-Aldrich ABN90), GFAP (Synaptic System 173–004), Synapsin II (Alomone ANR-015), GABA-B1 (Alomone AGB-001), MCHR1 (Thermo Fischer PA5-77492), Patched (Abcam ab53715), EP4 (Santa Cruz Biotechnology sc-55596), ANKS6 (Sigma HPA008355), NPHP3 (Proteintech 22026-1-AP), NEK8 (kind gift from Prof. David R. Beier, Seattle Children’s Hospital, USA).

Techniques: Immunofluorescence, Expressing, Cell Culture, Activation Assay, Activity Assay, Control, Two Tailed Test, Analysis, MANN-WHITNEY, Fluorescence

Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific for PP2Aα (top bands) and synapsin (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.

Journal:

Article Title: Long Term Synaptic Depression That Is Associated with GluR1 Dephosphorylation but Not ?-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Internalization *

doi: 10.1074/jbc.M803431200

Figure Lengend Snippet: Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 μg of total protein loaded) and un-X-linked (5.0 μg of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0μg of total protein loaded for both) samples probed with antibodies specific for PP2Aα (top bands) and synapsin (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D)(n = 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see “Experimental Procedures” for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H)(n = 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2Aα (I) and synapsin (J)(n = 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean ± S.E.

Article Snippet: Primary antibodies were as follows: GluR1 and GluR2/3 (Chemicon) used at 1:3000 in BSA, phospho-Ser-845 and phospho-Ser-831 (PhosphoSolutions) used at 1:1000 in BSA, PP2Aα (BD Pharmingen) used at 1:5000 in milk, synapsin, NR2B, and NR1 (PhosphoSolutions) used at 1:2000 in BSA, the α subunit of calcium/calmodulin-dependent protein kinase II (αCaMKII) (BD Pharmingen) used at 1:3000 in BSA, phospho-Thr-286 (PhosphoSolutions) used at 1:3000 in milk, PSD-95 (Affinity Bioreagents) used at 1:5000 in BSA, and transferrin receptor (Zymed Laboratories Inc.) used at 1:1000 in milk.

Techniques: Expressing, Control

Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels of PSD95, synapsin, synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.

Journal: International journal of molecular sciences

Article Title: Treadmill Exercise Alleviates Cognition Disorder by Activating the FNDC5: Dual Role of Integrin αV/β5 in Parkinson's Disease.

doi: 10.3390/ijms24097830

Figure Lengend Snippet: Figure 6. Effect of treadmill exercise on synaptic plasticity of hippocampal pyramidal neurons and dopamine levels and BDNF in MPTP-induced chronic PD mice model. (A) Total dopamine levels of the hippocampus (F(4,55) = 33.12, p < 0.001, n = 12). (B) Hippocampal protein levels of PSD95, synapsin, synaptophysin, SNAP47, TH, and BDNF were examined by Western blotting. (C–H) Quantification of PSD95 (F(4,10) = 53.50, p < 0.001), synapsin (F(4,10) = 99.18, p < 0.001), SNAP47 (F(4,10) = 60.12, p < 0.001), synaptophysin (F(4,10) = 17.47, p < 0.001), TH (F(4,10) = 83.36, p < 0.001),and BDNF (F(4,10) = 215.7, p < 0.001) levels. (n = 3). (I) Ultrastructure of synapses determined via electron micrography in hippocampus CA1 region of mice (scale bar = 500 nm). Enlarged images of the left images (scale bar = 125 nm). Red arrows indicate postsynaptic densities (PSDs), green arrows indicate the width of the synaptic cleft, blue arrows indicate the thickness of the PSD, and red dotted lines indicate the length of active synaptic zone. (J–L) Quantification of the length of the active synaptic zone (F(2,6) = 264.3, p < 0.001), synaptic cleft width (F(2,6) = 23.87, p = 0.001), and PSD thickness (F(2,6) = 21.17, p = 0.002), (n = 3). (M,N) Representative section of Golgi-Cox staining dendrites of CA1 pyramidal neurons from the stratum radiatum in mice. Spines number/10 µm (F(2,6) = 11.73, p = 0.009). Scale bars = 10 µm, 25 µm, and 100 µm; n = 3. Data represent the mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs.

Article Snippet: These primary antibodies included TH (1:1000, ab112, Abcam, Shanghai, China), PSD95 (1:1000, 3450S, CST, Fall River, MA, USA), Synapsin (1:1000, NB300-104, NOVUS (Shanghai) Co. Ltd, Centennial, CO, USA), CAMKII(1:1000, 50049S, CST, Fall River, MA, USA), SNAP47 (1:1000, ab172609, Abcam, Shanghai, China), Synaptophysin (1:1000, ab52636, Abcam, Shanghai, China), BDNF (1:200, ANT-010, Alomone Labs, Jerusalem, Israel), FNDC5 (1:1000, bs-8486R, Bioss, Beijing, China), integrin αV (1:200, sc-9969, Santa Cruz, Dallas, TX, USA), integrin β5 (1:200, sc398214, Santa Cruz, Dallas, TX, USA), and β-actin (1:5000, 60008-1-Ig, Proteintech, Wuhan, China).

Techniques: Western Blot, Staining, Control